Paper33643288
Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.
Koopman JJE and 4 others. Front Immunol, 2020. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys. Papers, record 33643288. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33643288
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement Inactivating Agents | Major topic |
| Complement Membrane Attack Complex | Major topic |
| Kidney | Major topic |
| Kidney Diseases | Major topic |
| Humans |
Source PubMed
References226
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32345771 | PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32345771 | PubMed |
| 2 | 27472742 | Complement activation and effect of eculizumab in scleroderma renal crisis. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/27472742 | PubMed |
| 3 | 21057849 | Membranoproliferative pattern of glomerular injury associated with complement component 9 deficiency due to Arg95Stop mutation. | Clin Exp Nephrol | 2011 | https://conductscience.org/library/papers/21057849 | PubMed |
| 4 | 30655025 | Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis. | Kidney Int | 2019 | https://conductscience.org/library/papers/30655025 | PubMed |
| 5 | 24924752 | Eculizumab treatment for rescue of renal function in IgA nephropathy. | Pediatr Nephrol | 2014 | https://conductscience.org/library/papers/24924752 | PubMed |
| 6 | 29725633 | Complement Activation in Patients With Diabetic Nephropathy. | Kidney Int Rep | 2018 | https://conductscience.org/library/papers/29725633 | PubMed |
| 7 | 2415178 | Monoclonal antibodies against neoantigens of the terminal C5b-9 complex of human complement. | Biosci Rep | 1985 | https://conductscience.org/library/papers/2415178 | PubMed |
| 8 | 12717204 | Complement activation in early protocol kidney graft biopsies after living-donor transplantation. | Transplantation | 2003 | https://conductscience.org/library/papers/12717204 | PubMed |
| 9 | 1720203 | Detection of polymorphonuclear cells, superoxide dismutase and poly C9 in glomeruli of patients with IgA nephropathy. | Nephron | 1991 | https://conductscience.org/library/papers/1720203 | PubMed |
| 10 | 31229026 | Terminal complement effectors in atypical hemolytic uremic syndrome: C5a, C5b-9, or a bit of both? | Kidney Int | 2019 | https://conductscience.org/library/papers/31229026 | PubMed |
| 11 | 28736435 | Extracellular vesicles in renal disease. | Nat Rev Nephrol | 2017 | https://conductscience.org/library/papers/28736435 | PubMed |
| 12 | 28819100 | Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy. | Sci Rep | 2017 | https://conductscience.org/library/papers/28819100 | PubMed |
| 13 | 2467771 | Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex. | Clin Exp Immunol | 1989 | https://conductscience.org/library/papers/2467771 | PubMed |
| 14 | 7607624 | Role of complement in renal tubular damage. | Histopathology | 1995 | https://conductscience.org/library/papers/7607624 | PubMed |
| 15 | 31787968 | Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics. | Front Immunol | 2019 | https://conductscience.org/library/papers/31787968 | PubMed |
| 16 | 9063527 | Immunohistochemistry of complement response on human renal cell carcinoma biopsies. | Tumori | 1996 | https://conductscience.org/library/papers/9063527 | PubMed |
| 17 | 30929519 | Role of Complement-Related Inflammation and Vascular Dysfunction in Hypertension. | Hypertension | 2019 | https://conductscience.org/library/papers/30929519 | PubMed |
| 18 | 3548335 | Ultrastructural localization of the membrane attack complex of complement in human renal tissues. | Am J Kidney Dis | 1987 | https://conductscience.org/library/papers/3548335 | PubMed |
| 19 | 30429287 | Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling. | J Immunol | 2018 | https://conductscience.org/library/papers/30429287 | PubMed |
| 20 | 1944729 | Homozygous C3 deficiency associated with IgA nephropathy. | Nephron | 1991 | https://conductscience.org/library/papers/1944729 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948706 | Correlation of Glomerular MBL Deposition with the Clinicopathology and Prognosis of Idiopathic Membranous Nephropathy: A PLA2R Subgroup Analysis. | Int J Gen Med | 2026 | https://conductscience.org/library/papers/42948706 | PubMed |
| 42939591 | Complement-Metabolic Inflammation Crosstalk: Molecular Mechanisms and Therapeutic Targets in Type 2 Diabetes and Its Complications. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42939591 | PubMed |
| 42852122 | Complement biomarkers in IgA nephropathy: current insights and clinical relevance. | Front Nephrol | 2026 | https://conductscience.org/library/papers/42852122 | PubMed |
| 42553762 | Programmed Cell Death: A Key Mechanism of Traditional Chinese Medicine in the Treatment of Membranous Nephropathy. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42553762 | PubMed |
| 42548161 | Clinicopathological features and outcomes of glomerular microangiopathy: a retrospective cohort study. | Ren Fail | 2026 | https://conductscience.org/library/papers/42548161 | PubMed |
| 42469261 | Internalized components of membrane attack complexes disrupt proteostasis and acquire alarmin-like properties. | Nat Commun | 2026 | https://conductscience.org/library/papers/42469261 | PubMed |
| 42427641 | Internalized Components of Membrane Attack Complexes Disrupt Proteostasis and Acquire Alarmin-Like Properties. | bioRxiv | 2026 | https://conductscience.org/library/papers/42427641 | PubMed |
| 42292840 | Tubulointerstitial inflammation and fibrosis induced by proteinuria: fresh insights. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42292840 | PubMed |
| 42106625 | Comparison of the efficacy of obinutuzumab versus rituximab combined with tacrolimus in the treatment of refractory membranous nephropathy. | BMC Nephrol | 2026 | https://conductscience.org/library/papers/42106625 | PubMed |
| 41872605 | The endothelium response to kidney injury. | Nat Rev Nephrol | 2026 | https://conductscience.org/library/papers/41872605 | PubMed |
| 41813685 | Design of miniprotein inhibitors targeting complement C9 to block membrane attack complex assembly. | Nat Commun | 2026 | https://conductscience.org/library/papers/41813685 | PubMed |
| 41807808 | Global research trends and hotspots in targeted therapy for IgA nephropathy: a bibliometric and visualization analysis (1999-2025). | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41807808 | PubMed |
| 41714421 | Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy. | Pediatr Nephrol | 2026 | https://conductscience.org/library/papers/41714421 | PubMed |
| 41608159 | Advances in Complement-Targeted Therapy for IgA Nephropathy. | Kidney Dis (Basel) | 2026 | https://conductscience.org/library/papers/41608159 | PubMed |
| 41591175 | The Pathological Role of LDL in Membranous Nephropathy and Diabetic Nephropathy and the Protective Efficacy of LDL Apheresis: A Narrative Review. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/41591175 | PubMed |
| 41404698 | Biomarkers in the Management of Complement-Mediated Kidney Diseases in the Era of Complement Therapeutics. | Clin J Am Soc Nephrol | 2026 | https://conductscience.org/library/papers/41404698 | PubMed |
| 41375892 | The Role of Complement Activation in Diabetic Nephropathy: Current Insights and Future Directions. | J Clin Med | 2025 | https://conductscience.org/library/papers/41375892 | PubMed |
| 41347971 | Update in the diagnosis of complement-mediated thrombotic microangiopathy/atypical hemolytic uremic syndrome. | Hematology Am Soc Hematol Educ Program | 2025 | https://conductscience.org/library/papers/41347971 | PubMed |
| 41272252 | Establishment of a Time-Resolved Fluoroimmunoassay for sC5b-9 and Validation in Lupus Nephritis. | J Fluoresc | 2026 | https://conductscience.org/library/papers/41272252 | PubMed |
| 41215783 | Alternative pathway-mediated tubular complement activation in human proteinuric kidney diseases: a proof-of-concept study. | Clin Kidney J | 2025 | https://conductscience.org/library/papers/41215783 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33643288
GET https://conductscience.org/api/papers/v1/33643288/references?page=2